Lang James Paul
SEC insider (Form 3/4/5 filer). CIK 0001703090. Director at OptimizeRx Corp (OPRX) and 2 other issuers. 9 reported Form 4/5 transactions since Sep 2024; latest on Jun 9, 2026. Located in WALTHAM, MA.
Companies Lang James Paul has filed insider reports for
- OptimizeRx Corp (OPRX): Director
- HALOZYME THERAPEUTICS, INC. (HALO): Director
- BIOVIE INC. (BIVI): Director
Lang James Paul
CIK: 0001703090
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (9 total)
- Jun 9, 2026OPRX
OptimizeRx Corp
AwardDirect34.5K shares- - May 5, 2026HALO
HALOZYME THERAPEUTICS, INC.
AwardDirect3.8K shares- - Jan 5, 2026BIVI
BIOVIE INC.
AwardDirectStock Option (right to buy)
330.5K shares- - Jan 5, 2026BIVI
BIOVIE INC.
AwardDirectStock Option (right to buy)
90K shares- - Jan 2, 2026HALO
HALOZYME THERAPEUTICS, INC.
AwardDirect889 shares- - Jun 11, 2025OPRX
OptimizeRx Corp
AwardDirect9.9K shares- - Mar 14, 2025OPRX
OptimizeRx Corp
PurchaseDirect321.4K shares at avg. $7.60$2.4M - Dec 20, 2024BIVI
BIOVIE INC.
AwardDirectStock Option (right to buy)
22.7K shares- - Nov 20, 2024BIVI
BIOVIE INC.
AwardDirectStock Option (right to buy)
61.6K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 9, 2026 |  OPRX OptimizeRx Corp | Award | 34,517 | - | $0 | Direct |
| May 5, 2026 |  HALO HALOZYME THERAPEUTICS, INC. | Award | 3,796 | - | $0 | Direct |
| Jan 5, 2026 |  BIVI BIOVIE INC. | Award Stock Option (right to buy) | 330,500 | - | - | Direct |
| Jan 5, 2026 | BIVI BIOVIE INC. | Award Stock Option (right to buy) | 90,000 | - | - | Direct |
| Jan 2, 2026 | HALO HALOZYME THERAPEUTICS, INC. | Award | 889 | - | $0 | Direct |
| Jun 11, 2025 | OPRX OptimizeRx Corp | Award | 9,868 | - | - | Direct |
| Mar 14, 2025 | OPRX OptimizeRx Corp | Purchase | 321,408 | $7.60 | $2,443,761 | Direct |
| Dec 20, 2024 | BIVI BIOVIE INC. | Award Stock Option (right to buy) | 22,690 | - | - | Direct |
| Nov 20, 2024 | BIVI BIOVIE INC. | Award Stock Option (right to buy) | 61,600 | - | - | Direct |
1-9 of 9 transactions